| Symbol | ABBV |
|---|---|
| Name | ABBVIE INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, Illinois, 60064-6400, United States |
| Telephone | +1 847 932-7900 |
| Fax | — |
| — | |
| Website | https://www.abbvie.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. The companys primary product is Humira, administered via injection. Additional info from NASDAQ: |
Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain
Read moreAbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026
Read moreBOTOX® Cosmetic (onabotulinumtoxinA) Empowers Women Entrepreneurs Through "The Confidence Collective" for Fourth Year
Read moreQuaggin Susan E 🟢 acquired 71 shares (1 derivative) of AbbVie Inc. (ABBV) at $217.49 Transaction Date: Mar 31, 2026 | Filing ID: 000004
Read moreRAPP EDWARD J 🟢 acquired 155 shares (1 derivative) of AbbVie Inc. (ABBV) at $217.49 Transaction Date: Mar 31, 2026 | Filing ID: 000006
Read moreAlpern Robert J 🟢 acquired 35 shares (1 derivative) of AbbVie Inc. (ABBV) at $217.49 Transaction Date: Mar 31, 2026 | Filing ID: 000007
Read moreAllergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®
Read more